JP2022500461A5 - - Google Patents
Info
- Publication number
- JP2022500461A5 JP2022500461A5 JP2021514550A JP2021514550A JP2022500461A5 JP 2022500461 A5 JP2022500461 A5 JP 2022500461A5 JP 2021514550 A JP2021514550 A JP 2021514550A JP 2021514550 A JP2021514550 A JP 2021514550A JP 2022500461 A5 JP2022500461 A5 JP 2022500461A5
- Authority
- JP
- Japan
- Prior art keywords
- corneal region
- patient
- composition according
- dryness
- region
- Prior art date
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18196126 | 2018-09-22 | ||
| EP18196126.9 | 2018-09-22 | ||
| EP18198440 | 2018-10-03 | ||
| EP18198440.2 | 2018-10-03 | ||
| EP18202041.2 | 2018-10-23 | ||
| EP18202041 | 2018-10-23 | ||
| PCT/EP2019/075406 WO2020058504A1 (en) | 2018-09-22 | 2019-09-20 | Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022500461A JP2022500461A (ja) | 2022-01-04 |
| JPWO2020058504A5 JPWO2020058504A5 (https=) | 2022-09-27 |
| JP2022500461A5 true JP2022500461A5 (https=) | 2022-09-27 |
Family
ID=68240699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021514550A Pending JP2022500461A (ja) | 2018-09-22 | 2019-09-20 | 眼表面の損傷および乾燥の症状の治療のための眼科用組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20210346313A1 (https=) |
| EP (1) | EP3852734A1 (https=) |
| JP (1) | JP2022500461A (https=) |
| KR (1) | KR20210080388A (https=) |
| CN (1) | CN112739335A (https=) |
| AU (2) | AU2019342426A1 (https=) |
| CA (1) | CA3111873A1 (https=) |
| IL (1) | IL281516A (https=) |
| PH (1) | PH12021550621A1 (https=) |
| SG (1) | SG11202102818YA (https=) |
| WO (1) | WO2020058504A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108348777B (zh) | 2015-09-30 | 2020-04-28 | 诺瓦利克有限责任公司 | 半氟化化合物和其组合物 |
| USRE50060E1 (en) | 2016-06-23 | 2024-07-30 | Novaliq Gmbh | Topical administration method |
| ES2969758T3 (es) | 2016-09-22 | 2024-05-22 | Novaliq Gmbh | Composiciones farmacéuticas para usar en la terapia de la blefaritis |
| US10813976B2 (en) | 2016-09-23 | 2020-10-27 | Novaliq Gmbh | Ophthalmic compositions comprising ciclosporin |
| PT3399962T (pt) | 2016-12-23 | 2020-09-03 | Novaliq Gmbh | Composição oftálmica para o tratamento da doença do olho seco |
| CA3058097C (en) | 2017-04-21 | 2024-01-02 | Novaliq Gmbh | Iodine compositions |
| KR20200059272A (ko) | 2017-09-27 | 2020-05-28 | 노바리크 게엠베하 | 안구 질환의 치료에서의 사용을 위한 라타노프로스트를 포함하는 안과적 조성물 |
| CN111182893A (zh) | 2017-10-04 | 2020-05-19 | 诺瓦利克有限责任公司 | 包含f6h8的眼用组合物 |
| EP3758676A1 (en) | 2018-03-02 | 2021-01-06 | Novaliq GmbH | Pharmaceutical compositions comprising nebivolol |
| KR102882058B1 (ko) | 2018-03-28 | 2025-11-07 | 노바리크 게엠베하 | 티몰롤을 포함하는 약제학적 조성물 |
| JP2021522219A (ja) | 2018-04-27 | 2021-08-30 | ノバリック ゲーエムベーハー | 緑内障の治療のためのタフルプロストを含む眼科用組成物 |
| CN113710228A (zh) | 2019-02-13 | 2021-11-26 | 诺瓦利克有限责任公司 | 用于治疗眼部新生血管形成的组合物和方法 |
| US12419933B2 (en) | 2019-09-06 | 2025-09-23 | Novaliq Gmbh | Ophthalmic composition for the treatment of uveitis |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19938668B4 (de) | 1999-08-14 | 2006-01-26 | Bausch & Lomb Inc. | Tränenersatzmittel |
| EP1494681A4 (en) * | 2002-04-16 | 2008-08-06 | Collagenex Pharm Inc | PROCESS FOR THE SIMULTANEOUS TREATMENT OF OCULAR ROSACEA AND ACNE ROSACEA |
| US10105441B2 (en) * | 2007-08-16 | 2018-10-23 | The Schepens Eye Research Institute, Inc. | Method for inhibiting or reducing dry eye disease by IL-1Ra |
| EP2335735A1 (en) | 2009-12-14 | 2011-06-22 | Novaliq GmbH | Pharmaceutical composition for treatment of dry eye syndrome |
| CN113679697A (zh) | 2012-09-12 | 2021-11-23 | 诺瓦利克有限责任公司 | 包含半氟化烷烃的混合物的组合物 |
| DK3181119T3 (da) * | 2012-09-12 | 2019-09-16 | Novaliq Gmbh | Semifluorerede alkansammensætninger til anvendelse ved behandling af keratoconjunctivitis sicca |
| CN106999402B (zh) * | 2014-10-09 | 2020-10-27 | 梅迪普罗都司股份有限公司 | 睫毛用清洗剂 |
| CN108348777B (zh) * | 2015-09-30 | 2020-04-28 | 诺瓦利克有限责任公司 | 半氟化化合物和其组合物 |
| ES2969758T3 (es) * | 2016-09-22 | 2024-05-22 | Novaliq Gmbh | Composiciones farmacéuticas para usar en la terapia de la blefaritis |
| CN111182893A (zh) * | 2017-10-04 | 2020-05-19 | 诺瓦利克有限责任公司 | 包含f6h8的眼用组合物 |
-
2019
- 2019-09-20 EP EP19786907.6A patent/EP3852734A1/en active Pending
- 2019-09-20 US US17/278,585 patent/US20210346313A1/en active Pending
- 2019-09-20 CA CA3111873A patent/CA3111873A1/en active Pending
- 2019-09-20 CN CN201980062052.2A patent/CN112739335A/zh active Pending
- 2019-09-20 SG SG11202102818YA patent/SG11202102818YA/en unknown
- 2019-09-20 JP JP2021514550A patent/JP2022500461A/ja active Pending
- 2019-09-20 WO PCT/EP2019/075406 patent/WO2020058504A1/en not_active Ceased
- 2019-09-20 AU AU2019342426A patent/AU2019342426A1/en not_active Abandoned
- 2019-09-20 KR KR1020217011860A patent/KR20210080388A/ko active Pending
-
2021
- 2021-03-15 IL IL281516A patent/IL281516A/en unknown
- 2021-03-18 PH PH12021550621A patent/PH12021550621A1/en unknown
-
2025
- 2025-06-06 US US19/231,354 patent/US20250295607A1/en active Pending
- 2025-06-10 AU AU2025204313A patent/AU2025204313A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022500461A5 (https=) | ||
| Murray et al. | The eye and inflammatory rheumatic diseases: The eye and rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis | |
| Baudouin et al. | Inflammation in Glaucoma: From the back to the front of the eye, and beyond | |
| Nijm et al. | Understanding the dual dilemma of dry eye and glaucoma: an international review | |
| JP2024116245A5 (https=) | ||
| Jaenen et al. | Ocular symptoms and signs with preserved and preservative-free glaucoma medications | |
| Park et al. | Clinical effects and safety of 3% diquafosol ophthalmic solution for patients with dry eye after cataract surgery: a randomized controlled trial | |
| Federici | The non-antibiotic properties of tetracyclines: clinical potential in ophthalmic disease | |
| US11865123B2 (en) | Methods of inhibiting pathological angiogenesis | |
| JP2015509500A5 (https=) | ||
| JPWO2020074697A5 (https=) | ||
| WO2019033119A1 (en) | TREATMENT OF OPHTHALMIC CONDITIONS SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY USING PHARMACEUTICAL AGENTS THAT ELIMINATE SENESCENT CELLS | |
| KR20210080388A (ko) | 안구 표면 손상 및 건조 증상 치료를 위한 안약 조성물 | |
| Lazreg et al. | Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications | |
| JPWO2020058504A5 (https=) | ||
| AU2020290443A1 (en) | Carabachol-bromonidine formulation to enhance anti-presbyopia effects | |
| Voss et al. | Non-infectious and non-hereditary diseases of the corneal epithelium | |
| US20230338307A1 (en) | Prophylactic agent, ameliorating agent, and therapeutic agent for dry eye | |
| Hashemian et al. | Ocular presentations of amyloidosis | |
| Bruce et al. | Anterior eye disease and therapeutics AZ | |
| El Fekih et al. | Successful management of dry eye disease with a new eye drop formulation combining hyaluronic acid, trehalose, and N-acetyl-aspartyl-glutamic acid (NAAGA) | |
| US20240216375A1 (en) | Use of sympathetic activation inhibitor and/or alpha 1-adrenergic receptor inhibitor in preparing medicine for treating dry eyes | |
| CN114040783A (zh) | 可用于治疗干眼症的组合物和方法 | |
| RU2021107208A (ru) | Офтальмологические композиции для лечения повреждения поверхности глаза и симптомов сухости глаз | |
| Qian et al. | Efficacy of 0.05% cyclosporine A on tear inflammatory cytokines and goblet cell function after corneal refractive surgery |